Seog Joon Han is a prominent inventor based in Simi Valley, California. He has made significant contributions to the field of biopharmaceuticals, holding 2 patents that focus on innovative protein engineering.

Latest Patents

His latest patents include "Variant Fc-polypeptides with enhanced binding to the neonatal Fc receptor." This invention describes variant Fc-fragments that exhibit higher affinity and binding activity to the neonatal Fc receptor (FcRn) at pH levels of 5-6, while maintaining lower affinity at physiological pH. Additionally, he has developed "Human FGF receptor and β-Klotho binding proteins," which provides compositions and methods related to antigen binding proteins that specifically bind to β-Klotho and various FGF receptors. These innovations have potential applications in treating conditions such as type 2 diabetes and metabolic syndrome.

Career Highlights

Seog Joon Han is currently employed at Amgen Inc., a leading biotechnology company known for its focus on innovative therapies. His work at Amgen has allowed him to contribute to groundbreaking research and development in the biopharmaceutical sector.

Collaborations

He collaborates with talented coworkers, including Susie Miki Harris and Ji Lu, who share his commitment to advancing biopharmaceutical innovations.

Conclusion

Seog Joon Han's contributions to the field of biopharmaceuticals through his patents and work at Amgen highlight his role as an influential inventor. His innovative approaches to protein engineering continue to pave the way for advancements in medical treatments.

Profile summary based on public USPTO records.